Property Summary

NCBI Gene PubMed Count 4
PubMed Score 0.00
PubTator Score 2.00

Knowledge Summary


No data available


  Disease Sources (1)

Disease Target Count P-value
ovarian cancer 8492 4.74148483697067E-9
osteosarcoma 7933 5.74377654141268E-9
posterior fossa group B ependymoma 1530 2.48297364391453E-8
atypical teratoid / rhabdoid tumor 4369 9.80494129405324E-5
intraductal papillary-mucinous neoplasm (IPMN) 3289 0.0193687393510239


Accession Q8IU53 Q2M1K1 Q8IUI3
Symbols C10orf5


 Compartment GO Term (0)

Gene RIF (2)

25446261 CASC2 plays a tumor suppressive role in glioma via negative regulation of miR-21, which may be a novel therapeutic target for treating gliomas.
15024726 Identification of CASC2, in a region of common allelic loss at chromosome 10q26 in endometrial cancer.

AA Sequence

KEPYSE                                                                     71 - 76

Text Mined References (6)

PMID Year Title
25446261 2015 Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
15489334 2004 The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
15164054 2004 The DNA sequence and comparative analysis of human chromosome 10.
15024726 2004 Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer.
14702039 2004 Complete sequencing and characterization of 21,243 full-length human cDNAs.
12477932 2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.